CAS: 1345675-02-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ETP46464 REF: AN-AG009CBOCAS: 1345675-02-6 | 99% | 158.00 €~490.00 € | Wed 08 May 24 |
 | ETP-46464 REF: TM-T2084CAS: 1345675-02-6 | 99.56% | 40.00 €~430.00 € | Wed 15 May 24 |
 | ETP-46464 REF: 3D-VDC67502CAS: 1345675-02-6 | Min. 95% | To inquire | Thu 20 Jun 24 |
Ref: AN-AG009CBO
| 10mg | 158.00 € | |
| 25mg | 307.00 € | |
| 50mg | 490.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
ETP-46464
CAS:1345675-02-6
ETP-46464 is an effective and specific ATR inhibitor (IC50: 25 nM).
Formula:
C30H22N4O2
Purity:
99.56%
Color and Shape:
Solid
Molecular weight:
470.52
- Inhibitors
- DNA Damage/DNA Repair
- DNA-PK
- PI3K/Akt/mTOR Signaling
- See more categories
- PI3K
- ATM/ATR
- mTOR
Ref: TM-T2084
| 2mg | 40.00 € | |
| 5mg | 60.00 € | |
| 10mg | 96.00 € | |
| 25mg | 172.00 € | |
| 50mg | 269.00 € | |
| 100mg | 430.00 € | |
| 1ml*10 (DMSO) | 66.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
ETP-46464
CAS:1345675-02-6
ETP-46464 is a platinum-based chemotherapy agent that is used in the treatment of cancer. It …
Formula:
C30H22N4O2
Purity:
Min. 95%
Molecular weight:
470.52 g/mol
Ref: 3D-VDC67502
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024
